MAP Pharmaceuticals

From WikiCover

Jump to: navigation, search

MAP Pharmaceuticals uses proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. The company has several proprietary product candidates in clinical development that address large market opportunities, including the two most advanced product candidates: a proprietary formulation of nebulized budesonide for the potential treatment of children with asthma, and a proprietary formulation of inhaled dihydroergotamine for the potential treatment of migraine.

Headquarters: Mountain View, California

Website: http://www.mappharma.com/

Name (required):

Comment:

Retrieved from "http://www.wikicover.com/MAP_Pharmaceuticals"